Navigation Links
CareFusion Reports Fourth Quarter and Fiscal 2011 Results
Date:8/8/2011

1.8221.8Diluted 224.0224.0224.0224.0Effective Tax Rate55.8%n/a(164.7)%33.0%____________1Reflects the impact of the divestiture of the International Surgical Products (ISP) business.2Reflects nonrecurring charges primarily related to the spinoff, nonrecurring restructuring and acquisition integration charges, nonrecurring gain on the sale of assets, and nonrecurring tax items. 3Adjusted financial information reflects GAAP results adjusted on a non-GAAP basis to exclude nonrecurring items noted.4Earnings per share calculations are performed separately for each adjustment presented. Therefore, the sum of the per share adjustments from the table above may not equal the adjusted per share totals presented. CAREFUSION CORPORATIONADJUSTED FINANCIAL INFORMATION(UNAUDITED)Fiscal Year Ended June 30, 2010DiscontinuedNonrecurring(in millions, except per common share amounts)GAAP Operations 1Items 2Adjusted 3Revenue $

3,472

$

-

$

-

$

3,472Cost of Products Sold1,740--1,740Gross Margin1,732--1,732Selling, General and Administrative Expenses1,121-(63)1,058Research and Development Expenses159--159Restructuring and Acquisition Integration Charges 15-(15)-Gain on the Sale of Assets(12)-12-Operating Income449-66515Interest Expense and Other, Net 108-(22)86Income Before Income Tax341-88429Provision for Income Tax183-(55)128Income from Continuing Operations158-143301Discontinued OperationsLoss from the Disposal of Discontinued Businesses, Net of Tax(8)8--Income from the Operations of Discontinued Businesses, Net of Tax44(44)--Income from Discontinued Operations, Net of Tax36(36)--Net Income

$

194

$

(36)

$

143

$

301Per Share Amounts: 4Basic Earnings per Common Share

$

0.88

$

(0.16)

$

0.65<
'/>"/>

SOURCE CareFusion Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. CareFusion and ResMed Announce Distribution Agreement for U.S. Hospital Market
2. CareFusion Will Host an Earnings Conference Call on Aug. 8 to Discuss the Results for the Fourth Quarter and Fiscal 2011
3. CareFusion to Acquire Pharmacy Automation Innovator Rowa
4. CareFusion Reports Third Quarter Rise in Revenue, Earnings
5. CareFusion Will Host an Earnings Conference Call on May 5 to Discuss the Results for the Third Quarter Fiscal 2011
6. CareFusion Acquires Technology for Sorting and Managing Dangerous Pharmaceutical Waste
7. CareFusion Announces Departure of Chief Operating Officer
8. CareFusion Completes Sale of Onsite Services Instrument Management and Repair Business
9. CareFusion Launches Innovative Vertebral Balloon That Gives Surgeons More Options to Treat Spinal Fractures
10. CareFusion Launches Compact Ventilator to Enhance Home-Based Patient Mobility
11. CareFusion Appoints Carlos M. Nunez, M.D. as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... and RALEIGH, N.C. , ... Communications, LLC (CTMC), and Integrated Clinical Trial Services, ... and retention for clinical trials announce that they ... Trial Marketing Services (i-CTMS). i-CTMS will provide a ... to pharmaceutical, biotechnology and medical device companies. ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... "Electrocardiogram (ECG) Devices - Global Trends, Estimates and ... http://photos.prnewswire.com/prnh/20130307/600769 Global Electrocardiogram ... by 2016. The North America ... share while Europe claims approximately ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  Immune Pharmaceuticals ... today that its Board of Directors has elected Mr. Daniel ... who continues as Chief Executive Officer of Immune. Mr. ... since 2013. Immune,s new Chairman, Mr. Daniel ... of shareholders and to continue to support the strategic vision ...
Breaking Medicine Technology:Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) ... live webcast on Tuesday, May 3, 2011 at 4:30 p.m. ... will provide a business and financial update and review first ... press release may be accessed from the Investors section of ...
... April 21, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... and teleconference with management to discuss first quarter 2011 financial ... Wednesday, May 4, 2011, at 8:00 a.m. Eastern Time (5:00 ... for the first quarter ended March 31, 2011 will be ...
Cached Medicine Technology:Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... member can be stressful and can pose health threats to ... Development and Family Studies, Penn State, received a $3 million ... effects of caregiving on familial caregivers. He will look at ... adult day care impacts the stress levels of all individuals ...
... halo surrounding highly-publicized marketing campaigns regarding sweetener reformulations is ... Starbucks and other brands that they will remove high ... into question in news articles by several experts and ... companies, marketing efforts and put forth scientifically substantiated facts ...
... June 30 MicroMass Communications, Inc., a leader in ... appointed veteran business executive and marketing strategist Richard Patterson ... He will spearhead the agency,s oncology business, reporting to ... , , Patterson brings almost three decades ...
... June 30 Delaware,s Partnership to Fight Chronic Disease (PFCD), ... a major part of comprehensive health reform, hosted a breakfast ... for chronic disease management and care. , ... every year and 75 percent - or $1.7 trillion - ...
... NDA - AllerNaze(TM) , , BSE: 500257 NSE: ... , MUMBAI, India, June 30 Pharmaceutical Major, Lupin Ltd. ... steroid (INS) product, AllerNaze(TM) (triamcinolone acetonide, USP) Nasal Spray, 50mcg ... will be the first market in which Lupin will launch ...
... women who feel sensitive to rejection based on their physical ... surgery than those who are less sensitive to appearance-based rejection. ... comments about their physical appearance. The ... Body Image , was conducted by Lora E. Park, ...
Cached Medicine News:Health News:Caregivers may benefit from adult day care 2Health News:Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 2Health News:Recent News Reports of Sweetener Reformulations Raise Questions About Motivations 3Health News:MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP, Group Account Director 2Health News:MicroMass Hires Veteran Relationship Marketing Strategist Richard Patterson As VP, Group Account Director 3Health News:Delaware's Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health 2Health News:Lupin Expands Branded Play 2Health News:Lupin Expands Branded Play 3Health News:Cosmetic surgery appeals to men, women with appearance-based rejection sensitivity 2
Lyphochek Whole Blood Metals Control contains the major heavy metals of toxicological and environmental importance for whole blood analysis....
Lyphochek Whole Blood Control is a unique product designed to monitor immunosuppressants, red cell folate and lead in whole blood assays. This control has three critical levels for each analyte and i...
qUAntify Plus Control is a combination urine dipstick and microscopic control. The control is available in either 12 mL centrifuge tubes or 120 mL flip-top squeeze bottles....
Lyphochek Maternal Serum Control is a trilevel product with analytes at clinically significant levels to monitor maternal serum analysis....
Medicine Products: